Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$467M |
| 2 |
CRH
CRH
|
+$449M |
| 3 |
Broadcom
AVGO
|
+$446M |
| 4 |
Philip Morris
PM
|
+$414M |
| 5 |
Kenvue
KVUE
|
+$347M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$494M |
| 2 |
ExxonMobil
XOM
|
+$443M |
| 3 |
Visa
V
|
+$433M |
| 4 |
Merck
MRK
|
+$402M |
| 5 |
Advanced Micro Devices
AMD
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.89% |
| 2 | Healthcare | 11.83% |
| 3 | Financials | 11.72% |
| 4 | Industrials | 11.2% |
| 5 | Consumer Discretionary | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NOTE
3651
DELISTED
FiscalNote
NOTE
| $53.2K | ﹤0.01% |
2,132
| – | – |
|
|
HYPD
3652
Hyperion DeFi Inc
HYPD
$35.5M
| $52.7K | ﹤0.01% |
397
+73
| +23% | +$11.7K |
|
3653
Grupo Aval
AVAL
$5.82B
| $52.6K | ﹤0.01% |
21,746
-27,207
| -56% | -$66.5K |
|
|
ORGN
3654
DELISTED
Origin Materials
ORGN
| $50.8K | ﹤0.01% |
1,323
+11
| +0.8% | +$864 |
|
3655
ARS Pharmaceuticals
SPRY
$579M
| $48.6K | ﹤0.01% |
12,857
+80
| +0.6% | +$525 |
|
|
OPTN
3656
DELISTED
OptiNose
OPTN
| $48.1K | ﹤0.01% |
2,608
+5
| +0.2% | +$90 |
|
3657
Dakota Gold
DC
$617M
| $48.1K | ﹤0.01% |
18,649
| – | – |
|
3658
Erasca
ERAS
$6.15B
| $47.1K | ﹤0.01% |
23,885
+1,974
| +9% | +$5.06K |
|
|
SRTA
3659
Strata Critical Medical Inc
SRTA
$421M
| $46.2K | ﹤0.01% |
17,830
| – | – |
|
3660
Rimini Street
RMNI
$457M
| $45.1K | ﹤0.01% |
20,482
+720
| +4% | +$2.19K |
|
3661
Precigen
PGEN
$1.94B
| $44.8K | ﹤0.01% |
31,524
+211
| +0.7% | +$299 |
|
|
TVRD
3662
Tvardi Therapeutics
TVRD
$20.1M
| $44.4K | ﹤0.01% |
733
+68
| +10% | +$6.38K |
|
3663
Denison Mines
DNN
$2.43B
| $44.1K | ﹤0.01% |
26,706
+1,711
| +7% | +$2.37K |
|
3664
Annexon
ANNX
$796M
| $43.6K | ﹤0.01% |
18,491
+29
| +0.2% | +$88 |
|
|
CARM
3665
DELISTED
Carisma Therapeutics
CARM
| $43.5K | ﹤0.01% |
10,279
| – | – |
|
|
TEF
3666
DELISTED
Telefonica
TEF
| $43.3K | ﹤0.01% |
+10,647
| New | +$43.1K |
|
3667
BRC Inc
BRCC
$122M
| $43.1K | ﹤0.01% |
11,996
| – | – |
|
3668
Atara Biotherapeutics
ATRA
$72.6M
| $42.9K | ﹤0.01% |
1,160
+6
| +0.5% | +$267 |
|
3669
HF Foods Group
HFFG
$80.7M
| $41.6K | ﹤0.01% |
10,480
| – | – |
|
3670
Nomura Holdings
NMR
$28.3B
| $41.5K | ﹤0.01% |
10,322
-6,785
| -40% | -$27K |
|
3671
Verrica Pharmaceuticals
VRCA
$89M
| $41.4K | ﹤0.01% |
1,066
| – | – |
|
3672
Cue Biopharma
CUE
$118M
| $40.6K | ﹤0.01% |
588
| – | – |
|
|
CDTX
3673
DELISTED
Cidara Therapeutics
CDTX
| $39.8K | ﹤0.01% |
2,111
+860
| +69% | +$16.9K |
|
|
CAMP
3674
DELISTED
CalAmp Corp.
CAMP
| $36.6K | ﹤0.01% |
3,926
+31
| +0.8% | +$519 |
|
|
WE
3675
DELISTED
WeWork Inc.
WE
| $36.1K | ﹤0.01% |
11,988
+96
| +0.8% | +$659 |
|
Similar funds
Invesco's Q3 2023 Portfolio in Review
As of Q3 2023, Invesco held 3,966 positions worth $371B, down 2.7% from $381B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Invesco's Q3 2023 filing shows 118 new, 2,175 increased, 1,355 reduced and 98 closed positions. Its largest new stake was Stellantis: 12,130,006 shares worth $232M. The largest sale was Microsoft, an estimated $494M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q3 2023 buy was Stellantis: 12,130,006 shares worth $232M.
- Invesco added most to Adobe in Q3 2023, an estimated $467M increase.
- Invesco's biggest Q3 2023 reduction was Microsoft, cutting an estimated $494M.
- Invesco fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $272M.
- Invesco's ten largest holdings make up 14% of its $371B portfolio in Q3 2023.
- Invesco opened 118 new positions and closed 98 in Q3 2023.
- Invesco's portfolio value fell 2.7% quarter-over-quarter to $371B.
Based on Invesco's 13F filing for Q3 2023, filed 13 Nov 2023.